| 183 | Humans |
| 146 | Indium Radioisotopes (diagnostic use) |
| 125 | Female |
| 114 | Male |
| 86 | Middle Aged |
| 70 | Animals |
| 66 | Adult |
| 60 | Aged |
| 39 | Somatostatin (analogs & derivatives) |
| 36 | Mice |
| 35 | Somatostatin (diagnostic use) |
| 29 | Radiopharmaceuticals (diagnostic use) |
| 26 | Indium (chemistry) |
| 25 | Tissue Distribution |
| 23 | Pentetic Acid (diagnostic use) |
| 23 | Antibodies, Monoclonal (diagnostic use) |
| 21 | Receptors, Somatostatin (analysis) |
| 21 | Prospective Studies |
| 21 | Iodine Radioisotopes (diagnostic use) |
| 20 | Sensitivity and Specificity |
| 20 | Indium Radioisotopes |
| 20 | Indium Radioisotopes (pharmacokinetics) |
| 19 | Time Factors |
| 19 | Rats |
| 18 | Carcinoembryonic Antigen (immunology) |
| 18 | Aged, 80 and over |
| 17 | Tomography, Emission-Computed, Single-Photon |
| 16 | Mice, Nude |
| 15 | Octreotide (diagnostic use) |
| 15 | Adolescent |
| 14 | Tomography, X-Ray Computed |
| 14 | Receptors, Somatostatin (metabolism) |
| 14 | Follow-Up Studies |
| 13 | Surface Properties |
| 13 | Rats, Wistar |
| 12 | Pentetic Acid (analogs & derivatives) |
| 11 | Thyroid Neoplasms (radionuclide imaging) |
| 11 | Radioimmunodetection |
| 11 | Organometallic Compounds (diagnostic use) |
| 11 | Mice, Inbred BALB C |
| 11 | Colorectal Neoplasms (radionuclide imaging) |
| 10 | Tumor Cells, Cultured |
| 10 | Tin Compounds (chemistry) |
| 10 | Octreotide (analogs & derivatives) |
| 10 | Neoplasm Transplantation |
| 10 | Neoplasm Recurrence, Local (radionuclide imaging) |
| 10 | Kinetics |
| 10 | Heart (radionuclide imaging) |
| 9 | Reproducibility of Results |
| 9 | Radioimmunotherapy |
| 9 | Phosphines (chemistry) |
| 9 | Particle Size |
| 9 | Myocardial Infarction (radionuclide imaging) |
| 9 | Adenocarcinoma (radionuclide imaging) |
| 8 | Treatment Outcome |
| 8 | Thyroid Neoplasms (pathology) |
| 8 | Radioimmunotherapy (methods) |
| 8 | Quantum Dots |
| 8 | Prognosis |
| 8 | Neoplasm Staging |
| 8 | Neoplasm Metastasis |
| 8 | Myosins (immunology) |
| 8 | Magnetic Resonance Imaging |
| 8 | Lung (radionuclide imaging) |
| 8 | Iodobenzenes (diagnostic use) |
| 8 | Iodine Radioisotopes (therapeutic use) |
| 8 | Electrodes |
| 8 | Child |
| 8 | Catalysis |
| 8 | Carcinoid Tumor (radionuclide imaging) |
| 8 | Antibodies, Monoclonal (immunology) |
| 8 | 3-Iodobenzylguanidine |
| 7 | Transplantation, Heterologous |
| 7 | Technetium (diagnostic use) |
| 7 | Radiopharmaceuticals (pharmacokinetics) |
| 7 | Predictive Value of Tests |
| 7 | Pancreatic Neoplasms (radionuclide imaging) |
| 7 | Oxyquinoline (analogs & derivatives) |
| 7 | Ovarian Neoplasms (radionuclide imaging) |
| 7 | Neuroendocrine Tumors (radionuclide imaging) |
| 7 | Molecular Structure |
| 7 | Lung (metabolism) |
| 7 | Liver Neoplasms (secondary) |
| 7 | Liver Neoplasms (radionuclide imaging) |
| 7 | Iodine Radioisotopes |
| 7 | Hydrogen-Ion Concentration |
| 7 | Blood Platelets |
| 7 | Antibody Specificity |
| 6 | Thyroid Neoplasms (radiotherapy) |
| 6 | Splenectomy |
| 6 | Spleen (radionuclide imaging) |
| 6 | Radioimmunodetection (methods) |
| 6 | Pentetic Acid (pharmacokinetics) |
| 6 | Oxidation-Reduction |
| 6 | Octreotide (therapeutic use) |
| 6 | Nanotechnology (methods) |
| 6 | Lymphatic Metastasis |
| 6 | Haptens |
| 6 | Equipment Design |
| 6 | Diagnosis, Differential |
| 6 | Computer Simulation |
| 6 | Child, Preschool |
| 6 | Cell Survival |
| 6 | Cell Line, Tumor |
| 6 | Bone and Bones (radionuclide imaging) |
| 6 | Bone Neoplasms (secondary) |
| 6 | Antibodies, Monoclonal |
| 6 | Administration, Oral |
| 5 | Zollinger-Ellison Syndrome (radionuclide imaging) |
| 5 | Technetium Tc 99m Medronate (diagnostic use) |
| 5 | Solubility |
| 5 | Retrospective Studies |
| 5 | Radiotherapy Dosage |
| 5 | Platelet Count |
| 5 | Pancreatic Neoplasms (metabolism) |
| 5 | Oxyquinoline (diagnostic use) |
| 5 | Organotechnetium Compounds (diagnostic use) |
| 5 | Models, Chemical |
| 5 | Microscopy, Electron, Scanning |
| 5 | Materials Testing |
| 5 | Lung Neoplasms (radionuclide imaging) |
| 5 | Indicators and Reagents |
| 5 | Immunohistochemistry |
| 5 | Immunoglobulin Fab Fragments (immunology) |
| 5 | Equipment Failure Analysis |
| 5 | Electrochemistry |
| 5 | Diagnostic Imaging |
| 5 | Cells, Cultured |
| 5 | Bone Neoplasms (radionuclide imaging) |
| 5 | Blood Platelets (physiology) |
| 5 | Antibodies, Monoclonal (pharmacokinetics) |
| 5 | Antibodies, Monoclonal (metabolism) |
| 5 | Antibodies, Monoclonal (chemistry) |
| 5 | Antibodies, Monoclonal (administration & dosage) |
| 5 | Antibodies, Bispecific (therapeutic use) |
| 5 | Algorithms |
| 5 | Adsorption |
| 5 | Acute Disease |
| 4 | Zinc Compounds (chemistry) |
| 4 | Tomography, Emission-Computed |
| 4 | Tomography, Emission-Computed, Single-Photon (methods) |
| 4 | Thyroid Neoplasms (metabolism) |
| 4 | Thyroid Neoplasms (diagnosis) |
| 4 | Temperature |
| 4 | Technetium |
| 4 | Somatostatin (pharmacokinetics) |
| 4 | Silicon (chemistry) |
| 4 | Semiconductors |
| 4 | Recurrence |
| 4 | Radionuclide Imaging (methods) |
| 4 | Preoperative Care |
| 4 | Positron-Emission Tomography (methods) |
| 4 | Permeability |
| 4 | Pentetic Acid |
| 4 | Neuroblastoma (radionuclide imaging) |
| 4 | Neoplasms (radiotherapy) |
| 4 | Nanotubes (chemistry) |
| 4 | Nanoparticles (chemistry) |
| 4 | Microscopy, Fluorescence |
| 4 | Microscopy, Atomic Force |
| 4 | Metabolic Clearance Rate |
| 4 | Lymph Nodes (radionuclide imaging) |
| 4 | Liver (radionuclide imaging) |
| 4 | Ligands |
| 4 | Isotope Labeling |
| 4 | Injections, Intravenous |
| 4 | Infant |
| 4 | Indium |
| 4 | Indium Radioisotopes (therapeutic use) |
| 4 | Indium Radioisotopes (administration & dosage) |
| 4 | Indium (diagnostic use) |
| 4 | Image Processing, Computer-Assisted |
| 4 | Heterocyclic Compounds, 1-Ring (chemistry) |
| 4 | Haptens (therapeutic use) |
| 4 | Gastrointestinal Neoplasms (radionuclide imaging) |
| 4 | Gallium (chemistry) |
| 4 | France |
| 4 | Fluorescence |
| 4 | Feasibility Studies |
| 4 | False Positive Reactions |
| 4 | Endocrine Gland Neoplasms (radionuclide imaging) |
| 4 | Electrocardiography |
| 4 | Drug Stability |
| 4 | Drug Carriers |
| 4 | Dogs |
| 4 | Crystallization (methods) |
| 4 | Coronary Angiography |
| 4 | Copper (chemistry) |
| 4 | Colonic Neoplasms (radiotherapy) |
| 4 | Chronic Disease |
| 4 | Cell Line |
| 4 | Carcinoma (radionuclide imaging) |
| 4 | Bone Marrow (radionuclide imaging) |
| 4 | Blood Platelets (pathology) |
| 4 | Arsenicals (chemistry) |
| 4 | Antigens, Neoplasm (immunology) |
| 4 | Antibodies, Monoclonal (therapeutic use) |
| 4 | Antibodies, Bispecific (diagnostic use) |
| 4 | Adrenal Gland Neoplasms (radionuclide imaging) |
| 3 | Water (chemistry) |
| 3 | Transferrin (diagnostic use) |
| 3 | Thyroglobulin (metabolism) |
| 3 | Thrombosis (diagnosis) |
| 3 | Technetium Tc 99m Exametazime |
| 3 | Sulfides (chemistry) |
| 3 | Stress, Mechanical |
| 3 | Stereoisomerism |
| 3 | Spleen (physiopathology) |
| 3 | Software |
| 3 | Receptors, Neurotensin (metabolism) |
| 3 | Radiopharmaceuticals (therapeutic use) |
| 3 | Radiopharmaceuticals (analysis) |
| 3 | Radionuclide Imaging |
| 3 | Radioimmunotherapy (adverse effects) |
| 3 | Purpura, Thrombocytopenic, Idiopathic (surgery) |
| 3 | Purpura, Thrombocytopenic, Idiopathic (blood) |
| 3 | Protein Binding |
| 3 | Primary Myelofibrosis (radionuclide imaging) |
| 3 | Positron-Emission Tomography |
| 3 | Porosity |
| 3 | Polymers (chemistry) |
| 3 | Photons |
| 3 | Peptides (chemistry) |
| 3 | Pentetic Acid (chemistry) |
| 3 | Paraganglioma (radionuclide imaging) |
| 3 | Pancreatic Neoplasms (diagnosis) |
| 3 | Oxygen (blood) |
| 3 | Ovarian Neoplasms (pathology) |
| 3 | Organometallic Compounds (pharmacokinetics) |
| 3 | Organometallic Compounds (chemistry) |
| 3 | Neutrophils (physiology) |
| 3 | Neuroendocrine Tumors (secondary) |
| 3 | Neuroblastoma (secondary) |
| 3 | Neoplasms (radionuclide imaging) |
| 3 | Nanotubes (ultrastructure) |
| 3 | Nanostructures (chemistry) |
| 3 | Myocardium (pathology) |
| 3 | Myocardial Infarction (physiopathology) |
| 3 | Myocardial Infarction (diagnosis) |
| 3 | Molecular Sequence Data |
| 3 | Molecular Conformation |
| 3 | Models, Structural |
| 3 | Microelectrodes |
| 3 | Mice, Inbred DBA |
| 3 | Mice, Inbred C57BL |
| 3 | Mathematics |
| 3 | Macrophages (immunology) |
| 3 | Lung Neoplasms (pathology) |
| 3 | Lung (pathology) |
| 3 | Lung (blood supply) |
| 3 | Liposomes (chemistry) |
| 3 | Indium Radioisotopes (metabolism) |
| 3 | Indium Radioisotopes (chemistry) |
| 3 | Indium Radioisotopes (analysis) |
| 3 | Immunoglobulin Fragments (metabolism) |
| 3 | Imines (chemistry) |
| 3 | Heart Diseases (diagnosis) |
| 3 | Head and Neck Neoplasms (radionuclide imaging) |
| 3 | Haptens (diagnostic use) |
| 3 | Half-Life |
| 3 | Guinea Pigs |
| 3 | Gallium Radioisotopes (diagnostic use) |
| 3 | Evaluation Studies as Topic |
| 3 | Edetic Acid (analogs & derivatives) |
| 3 | Echocardiography |
| 3 | Disease Progression |
| 3 | Disease Models, Animal |
| 3 | Crystallization |
| 3 | Combined Modality Therapy |
| 3 | Colorectal Neoplasms (pathology) |
| 3 | Colonic Neoplasms (metabolism) |
| 3 | Cardiomyopathies (radionuclide imaging) |
| 3 | Carcinoma, Medullary (secondary) |
| 3 | Carcinoma, Medullary (radionuclide imaging) |
| 3 | Carcinoid Tumor (secondary) |
| 3 | Carcinoembryonic Antigen (metabolism) |
| 3 | Carcinoembryonic Antigen (analysis) |
| 3 | Carbohydrates (chemistry) |
| 3 | Blood Vessel Prosthesis |
| 3 | Biocompatible Materials |
| 3 | Antigens, Tumor-Associated, Carbohydrate (immunology) |
| 3 | Antibodies, Bispecific (pharmacokinetics) |
| 3 | Antibodies, Bispecific (immunology) |
| 3 | Antibodies (metabolism) |
| 3 | Allyl Compounds (chemistry) |
| 3 | Adenoma (radionuclide imaging) |
| 3 | Adenocarcinoma (secondary) |
| 3 | Adenocarcinoma (metabolism) |
| 2 | Zinc Oxide (chemistry) |
| 2 | Zinc (chemistry) |
| 2 | Whole-Body Counting |
| 2 | Water |
| 2 | Ventricular Function, Left |
| 2 | Up-Regulation |
| 2 | Ultrasonography |
| 2 | Tumor Markers, Biological (metabolism) |
| 2 | Transplantation, Autologous |
| 2 | Transferrin (pharmacokinetics) |
| 2 | Tomography, X-Ray Computed (methods) |
| 2 | Tin Compounds |
| 2 | Thyroid Neoplasms (surgery) |
| 2 | Thyroid Neoplasms (chemistry) |
| 2 | Thrombosis (radionuclide imaging) |
| 2 | Thrombocytopenia (etiology) |
| 2 | Thrombocytopenia (diagnosis) |
| 2 | Thallium Radioisotopes |
| 2 | Thallium Radioisotopes (diagnostic use) |
| 2 | Technetium Tc 99m Sestamibi (diagnostic use) |
| 2 | Technetium Tc 99m Pentetate |
| 2 | Technetium Tc 99m Medronate (analogs & derivatives) |
| 2 | Syndrome |
| 2 | Survival Rate |
| 2 | Survival Analysis |
| 2 | Succinimides (chemistry) |
| 2 | Stomach (radionuclide imaging) |
| 2 | Stem Cell Transplantation |
| 2 | Staphylococcal Protein A (metabolism) |
| 2 | Staphylococcal Protein A (administration & dosage) |
| 2 | Spleen (pathology) |
| 2 | Spleen (abnormalities) |
| 2 | Spectrophotometry, Ultraviolet |
| 2 | Spectrophotometry, Ultraviolet (methods) |
| 2 | Spectrometry, Fluorescence |
| 2 | Somatostatin (metabolism) |
| 2 | Solutions |
| 2 | Skin Neoplasms (radionuclide imaging) |
| 2 | Silicon Dioxide (chemistry) |
| 2 | Sheep |
| 2 | Serum Albumin (metabolism) |
| 2 | Selenium Compounds (chemistry) |
| 2 | Sarcoidosis (radionuclide imaging) |
| 2 | Reoperation |
| 2 | Relative Biological Effectiveness |
| 2 | Reference Standards |
| 2 | Radiotherapy Planning, Computer-Assisted (methods) |
| 2 | Radiopharmaceuticals (chemistry) |
| 2 | Radiopharmaceuticals (adverse effects) |
| 2 | Radiopharmaceuticals (administration & dosage) |
| 2 | Radionuclide Imaging (instrumentation) |
| 2 | Radioisotopes (diagnostic use) |
| 2 | Radiation Dosage |
| 2 | ROC Curve |
| 2 | Quality Control |
| 2 | Purpura, Thrombocytopenic (surgery) |
| 2 | Pulmonary Alveoli (metabolism) |
| 2 | Postoperative Complications (radionuclide imaging) |
| 2 | Polycythemia Vera (radionuclide imaging) |
| 2 | Pituitary Neoplasms (radionuclide imaging) |
| 2 | Pheochromocytoma (radionuclide imaging) |
| 2 | Phantoms, Imaging |
| 2 | Phagocytosis |
| 2 | Peroxidases (metabolism) |
| 2 | Pentetic Acid (therapeutic use) |
| 2 | Pentetic Acid (metabolism) |
| 2 | Pentetic Acid (immunology) |
| 2 | Pancreatin (pharmacology) |
| 2 | Pancreatic Neoplasms (radiotherapy) |
| 2 | Pancreatic Neoplasms (pathology) |
| 2 | Oximes (diagnostic use) |
| 2 | Ovarian Neoplasms (therapy) |
| 2 | Ovarian Neoplasms (surgery) |
| 2 | Ovarian Neoplasms (metabolism) |
| 2 | Oligopeptides (diagnostic use) |
| 2 | Octreotide (pharmacokinetics) |
| 2 | Octreotide (administration & dosage) |
| 2 | Nitriles (chemistry) |
| 2 | Neutrophils (immunology) |
| 2 | Neoplasms (metabolism) |
| 2 | Neoplasms (diagnosis) |
| 2 | Neoplasm Staging (methods) |
| 2 | Necrosis |
| 2 | Nanotechnology (instrumentation) |
| 2 | Nanostructures (ultrastructure) |
| 2 | Nanoparticles (ultrastructure) |
| 2 | Myocardium (metabolism) |
| 2 | Myocarditis (radionuclide imaging) |
| 2 | Myocardial Infarction (surgery) |
| 2 | Myocardial Infarction (pathology) |
| 2 | Multivariate Analysis |
| 2 | Molecular Imaging (methods) |
| 2 | Models, Theoretical |
| 2 | Models, Statistical |
| 2 | Models, Biological |
| 2 | Microscopy, Electron, Transmission |
| 2 | Microscopy, Electron (methods) |
| 2 | Melanoma (radionuclide imaging) |
| 2 | Mediastinal Neoplasms (radionuclide imaging) |
| 2 | Mammary Neoplasms, Animal (pathology) |
| 2 | Magnetic Resonance Spectroscopy |
| 2 | Magnetic Resonance Imaging (methods) |
| 2 | Macrophages (physiology) |
| 2 | Macrophages (drug effects) |
| 2 | Macrophage Activation |
| 2 | Macromolecular Substances (chemistry) |
| 2 | Lysosomes (ultrastructure) |
| 2 | Lysosomes (metabolism) |
| 2 | Lymphatic Metastasis (radionuclide imaging) |
| 2 | Lymph Nodes (pathology) |
| 2 | Lymph Nodes (metabolism) |
| 2 | Lymph Nodes (immunology) |
| 2 | Lung Neoplasms (immunology) |
| 2 | Lung (drug effects) |
| 2 | Liver (metabolism) |
| 2 | Liposomes |
| 2 | Liposomes (metabolism) |
| 2 | Lipoproteins, LDL (diagnostic use) |
| 2 | Light |
| 2 | Kidney Neoplasms (radionuclide imaging) |
| 2 | Kidney (metabolism) |
| 2 | Isotope Labeling (methods) |
| 2 | Iodine Radioisotopes (pharmacokinetics) |
| 2 | Intraoperative Care (methods) |
| 2 | Intestinal Absorption |
| 2 | Interferon-gamma (pharmacology) |
| 2 | Integrin alphaVbeta3 (metabolism) |
| 2 | Injections, Intraperitoneal |
| 2 | Inflammatory Bowel Diseases (radionuclide imaging) |
| 2 | Indium Radioisotopes (immunology) |
| 2 | Indium (metabolism) |
| 2 | Immunotoxins (metabolism) |
| 2 | Immunoglobulin Fragments (chemistry) |
| 2 | Immunoglobulin Fab Fragments |
| 2 | Immunoglobulin Fab Fragments (metabolism) |
| 2 | Immunoglobulin Fab Fragments (diagnostic use) |
| 2 | Immunoglobulin Fab Fragments (chemistry) |
| 2 | Hydrogen (chemistry) |
| 2 | Heterocyclic Compounds, 1-Ring (diagnostic use) |
| 2 | Haptens (metabolism) |
| 2 | Haptens (immunology) |
| 2 | Haptens (administration & dosage) |
| 2 | Granulocytes |
| 2 | Glycosides (chemistry) |
| 2 | Glycosides (chemical synthesis) |
| 2 | Gastrointestinal Neoplasms (pathology) |
| 2 | Gastrointestinal Neoplasms (diagnosis) |
| 2 | Gastric Emptying (physiology) |
| 2 | Ganglioneuroblastoma (radionuclide imaging) |
| 2 | Gamma Rays |
| 2 | Gamma Cameras |
| 2 | Gallium Radioisotopes |
| 2 | Gadolinium (chemistry) |
| 2 | Fluorodeoxyglucose F18 (diagnostic use) |
| 2 | Fluorescent Dyes (pharmacokinetics) |
| 2 | Fluorescent Dyes (chemistry) |
| 2 | False Negative Reactions |
| 2 | Extremities (blood supply) |
| 2 | Extracellular Space (metabolism) |
| 2 | Exocytosis |
| 2 | Erythrocytes (physiology) |
| 2 | Erythrocytes (cytology) |
| 2 | Endocytosis |
| 2 | Endocrine Gland Neoplasms (pathology) |
| 2 | Endocrine Gland Neoplasms (diagnosis) |
| 2 | Electrochemistry (methods) |
| 2 | Electrochemical Techniques |
| 2 | Echocardiography, Doppler |
| 2 | Drug Evaluation |
| 2 | Drug Combinations |
| 2 | Dose-Response Relationship, Radiation |
| 2 | Dose Fractionation |
| 2 | Dosage Forms |
| 2 | Disaccharides (chemical synthesis) |
| 2 | Dinitrobenzenes (immunology) |
| 2 | Digestive System Neoplasms (radionuclide imaging) |
| 2 | Digestive System (metabolism) |
| 2 | Diagnostic Imaging (methods) |
| 2 | Coronary Circulation |
| 2 | Contrast Media |
| 2 | Computer-Aided Design |
| 2 | Colorectal Neoplasms (surgery) |
| 2 | Colorectal Neoplasms (immunology) |
| 2 | Colonic Neoplasms (radionuclide imaging) |
| 2 | Colonic Neoplasms (pathology) |
| 2 | Colon (radionuclide imaging) |
| 2 | Collagen (pharmacology) |
| 2 | Chemotaxis, Leukocyte |
| 2 | Chelating Agents |
| 2 | Chelating Agents (metabolism) |
| 2 | Chelating Agents (chemistry) |
| 2 | Cell Survival (physiology) |
| 2 | Cell Nucleus (radiation effects) |
| 2 | Cattle |
| 2 | Cations |
| 2 | Case-Control Studies |
| 2 | Cardiomyopathies (etiology) |
| 2 | Carcinoma, Small Cell (radionuclide imaging) |
| 2 | Carcinoma, Papillary (radionuclide imaging) |
| 2 | Carcinoma, Papillary (metabolism) |
| 2 | Carcinoma, Non-Small-Cell Lung (radionuclide imaging) |
| 2 | Carcinoma, Non-Small-Cell Lung (pathology) |
| 2 | Carcinoma, Non-Small-Cell Lung (blood) |
| 2 | Carcinoma, Medullary (pathology) |
| 2 | Carcinoma, Medullary (chemistry) |
| 2 | Carcinoma (therapy) |
| 2 | Carcinoma (pathology) |
| 2 | Carcinoma (metabolism) |
| 2 | Carcinoid Tumor (surgery) |
| 2 | Carcinoid Tumor (diagnosis) |
| 2 | Carbohydrate Sequence |
| 2 | Bronchial Neoplasms (radionuclide imaging) |
